Results 241 to 250 of about 2,209,314 (293)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Whipple Disease with Concurrent <i>Mycobacterium szulgai</i> Infection: A Rare Diagnostic and Therapeutic Challenge. [PDF]

open access: yesDiagnostics (Basel)
Giba N   +6 more
europepmc   +1 more source

Two-year outcomes following concomitant ACL and extra-articular ligament reconstruction: a nationwide analysis of over 5,000 patients. [PDF]

open access: yesArch Orthop Trauma Surg
Abid R   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy